Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
Hong Kong
· Delayed Price · Currency is HKD 4.940
+0.180 (3.78%)
At close: Mar 10, 2026
HKG:2185 Market Cap
HKG:2185 has a market cap or net worth of 1.16 billion as of March 10, 2026. Its market cap has increased by 164.44% in one year.
Market Cap
1.16B
Enterprise Value
1.02B
Revenue
22.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.94
Market Cap Chart
Since December 23, 2021, HKG:2185's market cap has decreased from 4.90B to 1.16B, a decrease of -76.37%. That is a compound annual growth rate of -29.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.16B | -17.79% |
| Dec 31, 2025 | 1.41B | 253.05% |
| Dec 31, 2024 | 399.20M | -52.05% |
| Dec 29, 2023 | 832.49M | -41.56% |
| Dec 30, 2022 | 1.42B | -78.41% |
| Dec 31, 2021 | 6.60B | 34.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wuhan YZY Biopharma | 1.10B |
| Beijing Biostar Pharmaceuticals | 1.37B |
| HighTide Therapeutics | 1.37B |
| CANbridge Pharmaceuticals | 1.39B |
| Kintor Pharmaceutical | 1.44B |
| Immunotech Biopharm | 1.45B |
| Transcenta Holding | 998.76M |
| Brii Biosciences | 995.72M |